e-LEA3D: a computational-aided drug design web server
- PMID: 20444867
- PMCID: PMC2896156
- DOI: 10.1093/nar/gkq322
e-LEA3D: a computational-aided drug design web server
Abstract
e-LEA3D web server integrates three complementary tools to perform computer-aided drug design based on molecular fragments. In drug discovery projects, there is a considerable interest in identifying novel and diverse molecular scaffolds to enhance chances of success. The de novo drug design tool is used to invent new ligands to optimize a user-specified scoring function. The composite scoring function includes both structure- and ligand-based evaluations. The de novo approach is an alternative to a blind virtual screening of large compound collections. A heuristic based on a genetic algorithm rapidly finds which fragments or combination of fragments fit a QSAR model or the binding site of a protein. While the approach is ideally suited for scaffold-hopping, this module also allows a scan for possible substituents to a user-specified scaffold. The second tool offers a traditional virtual screening and filtering of an uploaded library of compounds. The third module addresses the combinatorial library design that is based on a user-drawn scaffold and reactants coming, for example, from a chemical supplier. The e-LEA3D server is available at: http://bioinfo.ipmc.cnrs.fr/lea.html.
Figures


Similar articles
-
Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation.Comb Chem High Throughput Screen. 2009 May;12(4):383-96. doi: 10.2174/138620709788167971. Comb Chem High Throughput Screen. 2009. PMID: 19442066 Review.
-
The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections.Bioinformatics. 2011 Jul 15;27(14):2018-20. doi: 10.1093/bioinformatics/btr333. Epub 2011 Jun 2. Bioinformatics. 2011. PMID: 21636592
-
LEA3D: a computer-aided ligand design for structure-based drug design.J Med Chem. 2005 Apr 7;48(7):2457-68. doi: 10.1021/jm0492296. J Med Chem. 2005. PMID: 15801836
-
ACFIS: a web server for fragment-based drug discovery.Nucleic Acids Res. 2016 Jul 8;44(W1):W550-6. doi: 10.1093/nar/gkw393. Epub 2016 May 5. Nucleic Acids Res. 2016. PMID: 27150808 Free PMC article.
-
Free resources to assist structure-based virtual ligand screening experiments.Curr Protein Pept Sci. 2007 Aug;8(4):381-411. doi: 10.2174/138920307781369391. Curr Protein Pept Sci. 2007. PMID: 17696871 Review.
Cited by
-
A molecular evolution algorithm for ligand design in DOCK.J Comput Chem. 2022 Nov 5;43(29):1942-1963. doi: 10.1002/jcc.26993. Epub 2022 Sep 8. J Comput Chem. 2022. PMID: 36073674 Free PMC article.
-
Structure-based virtual screening for drug discovery: principles, applications and recent advances.Curr Top Med Chem. 2014;14(16):1923-38. doi: 10.2174/1568026614666140929124445. Curr Top Med Chem. 2014. PMID: 25262799 Free PMC article. Review.
-
Structure-activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches.Onco Targets Ther. 2016 Dec 2;9:7345-7353. doi: 10.2147/OTT.S108526. eCollection 2016. Onco Targets Ther. 2016. PMID: 27980424 Free PMC article.
-
A New Strategy for Multitarget Drug Discovery/Repositioning Through the Identification of Similar 3D Amino Acid Patterns Among Proteins Structures: The Case of Tafluprost and its Effects on Cardiac Ion Channels.Front Pharmacol. 2022 Mar 18;13:855792. doi: 10.3389/fphar.2022.855792. eCollection 2022. Front Pharmacol. 2022. PMID: 35370665 Free PMC article.
-
Changing Trends in Computational Drug Repositioning.Pharmaceuticals (Basel). 2018 Jun 5;11(2):57. doi: 10.3390/ph11020057. Pharmaceuticals (Basel). 2018. PMID: 29874824 Free PMC article. Review.
References
-
- Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature. 2004;432:855–861. - PubMed
-
- Triggle DJ. The chemist as astronaut: searching for biologically useful space in the chemical universe. Biochem. Pharmacol. 2009;78:217–223. - PubMed
-
- Blum LC, Reymond JL. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. J. Am. Chem. Soc. 2009;131:8732–8733. - PubMed
-
- Hartenfeller M, Proschak E, Schuller A, Schneider G. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization. Chem. Biol. Drug Des. 2008;72:16–26. - PubMed
-
- Masek BB, Shen L, Smith KM, Pearlman RS. Sharing chemical information without sharing chemical structure. J. Chem. Inf. Model. 2008;48:256–261. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical